This study evaluated key apoptotic regulators (BAD, BID, BCL2, MDM2, p53, PUMA) and the proliferation marker Ki-67 in stage II–III colorectal cancer to determine their prognostic relevance. This evidence concerns the gene MDM2 and colorectal cancer.